CryoPort Inc (NASDAQ:CYRX) price on Wednesday, May 09, fall -19.51% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.20.
A look at the stock’s price movement, the close in the last trading session was $16.40. Turning to its 52-week performance, $24.17 and $9.00 were the 52-week high and 52-week low respectively. Overall, CYRX moved -29.90% over the past month.
CryoPort Inc’s market cap currently stands at around $646.54 million.
Analysts have a consensus estimate of 60.27M for the company’s revenue for the quarter, with a low and high estimate of 57.4M and 61.98M respectively. The average forecast suggests up to a 1.50% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 245.6M, representing a 5.30% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CYRX is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
CYRX’s current price about -20.77% and -21.97% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.25, while 7-day volatility ratio is 10.22% and 5.97% in the 30-day chart. Further, CryoPort Inc (CYRX) has a beta value of 1.73, and an average true range (ATR) of 1.10.
If we refocus on CryoPort Inc (NASDAQ:CYRX), historical trading data shows that trading volumes averaged 454.15K over the past 3 months. The company’s latest data on shares outstanding shows there are 48.97 million shares.
The 2.31% of CryoPort Inc’s shares are in the hands of company insiders while institutional holders own 103.57% of the company’s shares. Current price change has pushed the stock -14.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CYRX stock continues to rise going into the next quarter.